Delivery Order SPE2DR25D2206-SPE2DR26F9EC6
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 1 mg/10 mL LuerJet auto-injectors in 10 mL units. The contract is a firm fixed-price delivery order with a ceiling value of $1,141.73 and an ultimate completion date of June 17, 2025. This award represents a non-competitive, single-award delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Epinephrine 1 mg/10 mL Luerjet auto-injectors in 10 mL units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,109.70 and is scheduled for completion by September 15, 2025. The contract is not designated as a set-aside and represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 1 mg/10 mL LuerJet auto-injectors with a ceiling value of $1,336.96. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,333.86 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/10 mL LuerJet auto-injectors on a firm fixed price basis. The award was made on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-competitive delivery order. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,508.05 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/10 mL LuerJet auto-injectors on June 4, 2025, with an ultimate completion date of June 5, 2025. This non-competitive delivery order utilizes a firm fixed-price structure and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, valued at $2,738.77. This is a firm fixed-price delivery order with an ultimate completion date of December 5, 2025, and represents performance at the company's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without any set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Epinephrine 1 mg/10 mL LuerJet auto-injectors with a contract ceiling value of $2,953.92 and an ultimate completion date of June 30, 2025. This competitive award, issued under a firm fixed-price delivery order arrangement with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 1 mg/10 ml LuerJet auto-injectors with a ceiling value of $2,887.20 and an ultimate completion date of July 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was competitively contested. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $13,764.06 and a firm fixed price structure. The order is set to be completed by December 2, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which...
- The Defense Logistics Agency awarded a $1,303.20 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Epinephrine 1 mg/10 mL Luerjet auto-injectors in 10 mL quantities, with a completion date of August 8, 2025. This contract utilizes firm fixed pricing and represents a non-set-aside, competitively awarded procurement. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9EC6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Epinephrine 1 mg/10 mL Luerjet 10 mL auto-injectors, with a ceiling value of $3,089.34 and an ultimate completion date of December 4, 2025. This is a firm fixed-price delivery order issued without set-aside designation, indicating competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary distribution center for federal pharmaceutical contracts. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. The epinephrine auto-injector award reflects the company's role in supporting emergency medical preparedness for the Defense Health Agency and other federal healthcare systems through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 12/2/25 |